Rocuronium Bromide 10mg | 10mL Injectable MDV
MEI-71288071811
Meitheal Pharmaceuticals
-
RX License on File Required to Order
Detail
Paralytic Agent
The MEI-71288071811 Rocuronium Bromide 10mg/mL Injectable MDV is a high-quality, non-depolarizing neuromuscular blocking agent used primarily as an adjunct to general anesthesia to facilitate endotracheal intubation and relax skeletal muscles during surgery or mechanical ventilation. Rocuronium Bromide acts quickly and effectively, providing a reliable option for muscle relaxation with a well-controlled onset and duration of action. Packaged in a box of 10 multi-dose vials (MDV), it is ideal for use in hospital and surgical settings, ensuring that anesthesia teams have convenient, ready access to this essential agent.
Key Features:
- Non-Depolarizing Neuromuscular Blocker: Rocuronium Bromide allows for controlled muscle relaxation without causing the initial fasciculations commonly seen with depolarizing agents
- Rapid Onset: Typically achieves full effect within 1-2 minutes of administration, facilitating timely intubation
- Controlled Duration: Provides muscle relaxation for approximately 30-60 minutes, allowing for smooth transition through surgical or ventilated procedures
- 10mL Multi-Dose Vial (MDV): Convenient for dosing flexibility, especially in high-use settings where multiple doses may be required
- Box of 10 Vials: Economical packaging ensures sufficient supply for continuous use in operating rooms, intensive care units, and emergency settings
Benefits:
- Effective Muscle Relaxation: Ensures complete muscle relaxation for surgical procedures, allowing for smoother and safer patient management during anesthesia
- Reliable Intubation Support: The rapid onset of action provides efficient intubation conditions, enhancing patient safety and clinical efficiency
- Flexibility and Dosing Precision: Multi-dose vial format allows healthcare providers to adjust doses precisely based on patient needs, minimizing waste
- Reduces Anesthetic Requirements: Rocuronium’s muscle-relaxing effects reduce the need for higher levels of general anesthetics, aiding in smoother patient recovery